References
- Lei P, Dandekar O, Widlus D, Shekhar R. Incorporation of preprocedural PET into CT-guided radiofrequency ablation of hepatic metastases: a nonrigid image registration validation study. J Digit Imaging. 2010;23:780–92.
- Cornelis F, Silk M, Schoder H, et al. Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities. Eur J Nucl Med Mol Imaging. 2014;41:2265–72.
- Cazzato RL, Garnon J, Ramamurthy N, et al. 18F-FDOPA PET/CT-guided radiofrequency ablation of liver metastases from neuroendocrine tumours: technical note on a preliminary experience. Cardiovasc Intervent Radiol. 2016;39:1315–21.
- Guo W, Hao B, Chen H, et al. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique. Eur J Nucl Med Mol Imaging. 2017;44:25–32.
- Shyn PB, Tatli S, Sahni VA, et al. PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition. Clin Radiol. 2014;69:410–5.
- Fei B, Schuster DM. PET molecular imaging-directed biopsy: a review. AJR Am J Roentgenol. 2017;209:255–69.
- Maybody M, Grewal RK, Healey JH, et al. Ga-68 DOTATOC PET/CT-guided biopsy and cryoablation with autoradiography of biopsy specimen for treatment of tumor-induced osteomalacia. Cardiovasc Intervent Radiol. 2016;39:1352–7.
- Sainani NI, Shyn PB, Tatli S, et al. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation? J Vasc Interv Radiol. 2011;22:354–60.
- Ryan ER, Sofocleous CT, Schoder H, et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology. 2013;268:288–95.
- Shyn PB. Interventional positron emission tomography/computed tomography: State-of-the-art. Tech Vasc Interv Radiol. 2013;16:182–90.
- Cornelis F, Storchios V, Violari E, et al. 18F-FDG PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation. J Nucl Med. 2016;57:1052–7.
- Ryan ER, Thornton R, Sofocleous CT, et al. PET/CT-guided interventions: Personnel radiation dose. Cardiovasc Intervent Radiol. 2013;36:1063–7.
- Grasso RF, Cazzato RL, Luppi G, et al. Percutaneous lung biopsies: performance of an optical CT-based navigation system with a low-dose protocol. Eur Radiol. 2013;23:3071–6.
- Grasso RF, Faiella E, Luppi G, et al. Percutaneous lung biopsy: comparison between an augmented reality CT navigation system and standard CT-guided technique. Int J Cars. 2013;8:837–48.
- Schullian P, Widmann G, Lang TB, et al. Accuracy and diagnostic yield of CT-guided stereotactic liver biopsy of primary and secondary liver tumors. Comput Aided Surg. 2011;16:181–7.
- Widmann G, Schullian P, Haidu M, et al. Targeting accuracy of CT-guided stereotaxy for radiofrequency ablation of liver tumours. Minim Invasive Ther Allied Technol. 2011;20:218–25.
- Widmann G, Schullian P, Haidu M, et al. Respiratory motion control for stereotactic and robotic liver interventions. Int J Med Robot 2010;6:343–9.
- Cerci JJ, Tabacchi E, Bogoni M, et al. Comparison of CT and PET/CT for biopsy guidance in oncological patients. Eur J Nucl Med Mol Imaging. 2017;44:1269–74.